Structure-based development of a subtype-selective orexin 1 receptor antagonist.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: 2020-07-28

DOI: 10.1073/pnas.2002704117

Affiliations: 4

Authors: 12

Go to article
Institutions Share
Department of Chemistry and Pharmacy (DCP), FAU, Germany 0.50
Institute of Pharmaceutical Chemistry (IPC), Uni Marburg, Germany 0.25
Department of Biophysics, UT Southwestern Medical Center, United States of America (USA) 0.17
Drug Discovery Biology (DDB), Monash University, Australia 0.08

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER